Nurix Therapeutics (NRIX) Interest & Investment Income: 2019-2025
Historic Interest & Investment Income for Nurix Therapeutics (NRIX) over the last 6 years, with Aug 2025 value amounting to $5.0 million.
- Nurix Therapeutics' Interest & Investment Income fell 13.47% to $5.0 million in Q3 2025 from the same period last year, while for Aug 2025 it was $23.2 million, marking a year-over-year increase of 36.62%. This contributed to the annual value of $19.7 million for FY2024, which is 77.49% up from last year.
- Nurix Therapeutics' Interest & Investment Income amounted to $5.0 million in Q3 2025, which was down 11.64% from $5.6 million recorded in Q2 2025.
- Over the past 5 years, Nurix Therapeutics' Interest & Investment Income peaked at $6.5 million during Q1 2025, and registered a low of $39,000 during Q3 2021.
- Over the past 3 years, Nurix Therapeutics' median Interest & Investment Income value was $4.1 million (recorded in 2024), while the average stood at $4.4 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 94.22% in 2021, then surged by 2,487.18% in 2022.
- Nurix Therapeutics' Interest & Investment Income (Quarterly) stood at $295,000 in 2021, then spiked by 568.81% to $2.0 million in 2022, then spiked by 71.21% to $3.4 million in 2023, then soared by 81.05% to $6.1 million in 2024, then declined by 13.47% to $5.0 million in 2025.
- Its Interest & Investment Income stands at $5.0 million for Q3 2025, versus $5.6 million for Q2 2025 and $6.5 million for Q1 2025.